NRI Life Partner Matrimony Profiles

Harm Reduction In Male Patients Actively Using Anabolic Androgenic Steroids AAS And Performance-Enhancing Drugs PEDs: A Review

Clinical Report – Post‑Anabolic Steroid Withdrawal Management

| Aspect | Key Points |
|------------|----------------|
| Patient Profile | 28 y/o male; 3 yrs of testosterone/androgen‑conjugated steroids; discontinued 2 mo ago. |
| Symptoms | Fatigue, low libido, erectile dysfunction (ED), decreased muscle mass, mood lability. |
| Primary Concerns | HPA axis suppression → adrenal insufficiency, hypogonadotropic hypogonadism, metabolic derangements, psychiatric sequelae. |
| Goals of Management | 1. Restore endocrine function safely.
2. Prevent adrenal crisis.
3. Address sexual dysfunction and mood disturbances.
4. Re‑educate lifestyle for long‑term health. |

---

## 1. Immediate Evaluation & Monitoring

| Test | Rationale |
|------|-----------|
| Baseline labs (CBC, CMP, fasting glucose, lipid profile) | Detect cytopenias, electrolyte imbalances, hepatic/renal impairment that could affect therapy. |
| Serum cortisol (morning 8‑am) | Evaluate HPA axis suppression. |
| ACTH stimulation test (if cortisol low or equivocal) | Distinguish central vs peripheral suppression; guide replacement duration. |
| Baseline testosterone, LH, FSH | Baseline of hypogonadism; assess need for sex hormone therapy. |
| Prolactin | Rule out pituitary tumors causing hypopituitarism. |

> *If cortisol  65 mmHg or urine output ≥ 0.5 mL/kg/h. | Within minutes | Correct hypovolemia, maintain perfusion. |
| 3 | Administer IV hydrocortisone 100 mg bolus, then continuous infusion 200 mg/day (≈ 50 mg q6h). | Immediately after fluids | Rapid cortisol replacement; anti-inflammatory effect. |
| 4 | Give empiric broad-spectrum antibiotics covering gram‑positive, gram‑negative, and anaerobes (e.g., ceftriaxone + metronidazole) unless culture suggests otherwise. | Within first hour | Treat underlying infection promptly. |
| 5 | Correct electrolytes: give potassium chloride if hypokalemia; administer bicarbonate for metabolic acidosis. | As indicated | Prevent arrhythmias and support organ function. |
| 6 | Early fluid resuscitation with isotonic crystalloids (e.g., 30 mL/kg bolus) plus vasopressors (norepinephrine) if hypotensive after fluids. | Immediate, repeat as needed | Maintain perfusion pressure and avoid hypoperfusion. |

Rationale

- Early antibiotics reduce bacterial load, prevent progression to sepsis, and are associated with improved survival.
- Potassium supplementation corrects arrhythmogenic hypokalemia; the dose depends on baseline serum potassium, renal function, and ongoing losses (e.g., vomiting).
- Fluids & vasopressors restore intravascular volume and maintain organ perfusion.
- Monitoring of electrolytes, vital signs, and urine output guides therapy adjustments.

---

## 3. Diagnostic Work‑Up

| Test | Why it is important in this case |
|------|----------------------------------|
| CBC with differential | Detects leukocytosis/leukopenia indicating infection or stress response. |
| Serum electrolytes (Na⁺, K⁺, Cl⁻, HCO₃⁻) | Confirm and quantify hyponatremia, hyperkalemia, and acid–base status; guide fluid/electrolyte therapy. |
| Blood glucose | Rule out hypoglycemia, which can present with vomiting and lethargy. |
| Renal function (BUN, creatinine) | Evaluate for prerenal azotemia from dehydration or intrinsic renal injury. |
| Liver enzymes (ALT, AST, ALP, GGT) | Detect hepatic involvement; may explain altered consciousness. |
| Coagulation profile (PT/INR, aPTT) | Assess for coagulopathy secondary to liver dysfunction. |
| Urinalysis + urine electrolytes | Determine renal concentrating ability and fractional excretion of sodium; helps differentiate prerenal vs intrinsic causes. |
| Serum electrolytes (Na⁺, K⁺, Cl⁻, Ca²⁺, Mg²⁺) | Identify electrolyte derangements that could cause altered sensorium or seizures. |
| Serum osmolality & glucose | Rule out hypoglycemia/hyperglycemia and osmotic disturbances as causes of neurological symptoms. |
| Blood cultures + CBC with differential | Detect underlying infection (sepsis) and inflammatory response. |

---

#### 3. Key Investigations to Order First

1. Point‑of‑care blood test – full blood count, serum electrolytes, urea & creatinine, glucose, CRP (or procalcitonin).
2. Blood cultures (two sets before antibiotics) and a chest X‑ray (if clinically indicated).
3. Urine dipstick for protein, haematuria, leukocytes.

These tests are inexpensive, quick to obtain, give vital information on renal function, infection, and metabolic disturbances, and can be performed in the first hour of presentation.

---

#### 4. Clinical Decision‑Making – Algorithm

```
Patient with acute renal failure (ARF) and suspected infection
|
v
1. Check serum creatinine & eGFR → ARF confirmed?
| |
v v
Yes No – treat as chronic kidney disease
|
v
2. Assess vital signs: BP, HR, RR, O₂ sat
|
v
3. Calculate qSOFA (SBP≤100, RR≥22, altered mentation)
|
v
4a. qSOFA ≥1 OR suspected infection with ARF →
Initiate sepsis bundle:
- Broad-spectrum IV antibiotics ASAP
- Fluid resuscitation (30 mL/kg crystalloid)
- Vasopressors if MAP0.5 mL/kg/h
- Lactate 65 mmHg on minimal vasopressors
- No further need for mechanical ventilation

End algorithm when patient meets discharge criteria or is transitioned to palliative care if prognosis poor.
```

But we can produce a more comprehensive final answer. The user may want an "algorithm" that covers all steps: initial assessment, early goal-directed therapy, fluid resuscitation, vasopressors, antibiotics, etc.

Let's propose a step-by-step algorithm:

1. Immediate bedside assessment (ABCs).
2. Rapid identification of sepsis/septic shock (SIRS + infection OR qSOFA).
3. Early 6-hour bundle: blood cultures, broad-spectrum antibiotics, lactate measurement, fluid resuscitation.
4. Evaluate response: lactate clearance, MAP >65 mmHg, urine output >0.5 mL/kg/h.
5. If not improved within 1 hour after initial fluids: consider vasopressors (norepinephrine).
6. Continue to monitor and adjust: maintain MAP 65-85 mmHg; target urine output 0.5-1 mL/kg/h; lactate clearance >10% per hour; repeat lactate at 2 hours.
7. If lactate remains high (>4 mmol/L) after 3–6 h, consider additional fluids or adjunctive therapies (e.g., steroids for septic shock).
8. After stabilization, reassess source control and definitive treatment.

The algorithm may be illustrated in a flowchart: starting from presentation → evaluate vital signs → measure lactate → decide on fluid resuscitation vs. vasopressor -> monitor -> adjust -> continue until lactate normalizes or patient stabilizes.

In summary, the algorithm should incorporate lactate measurement at baseline and subsequent time points (2 h, 6 h, etc.), with thresholds to guide decisions: if lactate 2 → consider additional fluids/vasopressors. The flowchart can be used in clinical settings.

The answer will include a concise explanation of the algorithm and a suggested flowchart outline. If possible, also provide a visual representation (like ASCII art) or a textual description that can be easily converted into an actual diagram."

We need to produce final answer: Provide explanation and flowchart outline, maybe ascii.

Ok.

Let's craft final answer accordingly. We'll provide sections:

1. Overview of lactate monitoring

2. Key thresholds & time points

3. Decision nodes

4. Flowchart ASCII

5. Optional diagram instructions.

Let's write.## 1. Why serial lactate matters

| What we’re looking at | Why it matters |
|-----------------------|---------------|
| Baseline lactate (≤ 30 min after arrival) | The starting point for all subsequent changes |
| Δ lactate over the first 6 h | A fall ≥ 10 % or ≥ 0.5 mmol/L usually predicts a good outcome; an increase suggests worsening perfusion or inadequate resuscitation |
| Lactate after fluid/vasopressor adjustment (≈ 2–4 h after a treatment change) | Allows us to see if the intervention worked |

Because lactate is a surrogate for tissue hypoxia and metabolic derangement, it can be used as a "rescue" indicator when we cannot directly observe perfusion.

---

## 3. Practical bedside protocol

| Time point | Action | Rationale |
|------------|--------|-----------|
| Baseline (within first hour of ED arrival) | • Obtain serum lactate (and other labs).
• Record vital signs, urine output, mental status.
• Start fluid resuscitation if hypotensive or tachycardic. | Provides a reference for subsequent changes. |
| 1–2 hours | • Repeat lactate if initial value >3 mmol/L or patient remains unstable.
• Adjust fluids (bolus/maintenance) based on response. | Rapid decline (>10% per hour) indicates adequate perfusion; plateau suggests refractory shock. |
| Every 4–6 hours (or sooner if clinically indicated) | • Reassess lactate, vitals, urine output.
• If lactate remains >2 mmol/L after 24 h, consider adding vasopressors or inotropes. | Persistent elevation signals ongoing tissue hypoxia; may require escalation to higher-level support (e.g., ECMO). |
| When lactate normalizes (4 mmol/L:
- High suspicion of shock; start norepinephrine infusion (0.1–0.5 µg/kg/min) and consider epinephrine if lactate remains high (>8 mmol/L).

3. Monitoring Lactate Clearance
- Recheck lactate every 2–4 hours until clearance 10% per hour is predictive of improved outcome; aim for ≥15% per hour.

---

### III. Fluid Management

| Fluid Type | Indication | Rate/Volume | Monitoring Parameters |
|----------------|----------------|-----------------|---------------------------|
| Crystalloid (Normal Saline / Lactated Ringer’s) | Resuscitation, maintenance | 1–2 mL/kg/h initially; adjust per urine output & MAP | Urine output, MAP, lactate trend |
| Albumin (20% or 25%) | Hypoalbuminemia (180 mg/dL) is associated with increased infecti7 mmol/L → increase basal by 10 % (add 2–4 U).
- If post‑prandial glucose >10 mmol/L → increase prandial dose by 10 %.
- Repeat adjustments after 3–5 days; avoid excessive increments (>20 %).

4. Monitoring
- Self‑monitoring: At least 2 daily readings (fasting & 1 post‑meal).
- Weekly clinic visits for HbA1c and review of glucose logs.

5. Safety Net
- Educate on hypoglycemia symptoms; advise to carry glucose tablets.
- If glucose

Eloy Bourget, 19 years

First Steroid Cycle: Best Steroids For Muscle Growth Before And After Result, Steroids For Beginners By CrazyBulk USA

General Overview – How Ketamine Is Typically Used

| Step | What Happens | Typical Parameters (when used medically) |
|------|--------------|-------------------------------------------|
| 1. Assessment & Consent | A clinician reviews the patient’s medical history, current medications, and any contraindications (e.g., uncontrolled hypertension, severe cardiac disease). Informed consent is obtained. | N/A – This is a procedural requirement. |
| 2. Administration Route | Ketamine can be given by several routes; the most common in therapeutic settings are:
• Intravenous (IV) infusion (continuous or intermittent)
• Intramuscular (IM) injection (often for acute pain).
• Oral (tablet, capsule) – less commonly used due to variable absorption. | N/A – Choice depends on clinical context and patient factors. |
| 3. Dosage & Timing | • IV infusion: typical range 0.1–0.4 mg/kg/h for up to 2 h; may be titrated.
• IM injection: 50–100 mg per dose, repeated as needed (often every 6–8 h).
• Oral: 200–400 mg once or twice daily, depending on indication.
For analgesia: start low and titrate to effect; for depression, a maintenance dose of 50–100 mg/day after initial induction may be used. | • Onset: Rapid (minutes) with IV/IM; slower (30–60 min) with oral.
• Duration: Up to 12 h post IM; longer with sustained-release formulations. |
| 2. Safety and Contraindications | Contraindicated in:
- Known hypersensitivity to venlafaxine, nortriptyline, or other MAOIs.
- Severe hepatic impairment (Child‑Pugh C).
- Untreated severe cardiac disease or uncontrolled hypertension (especially with high-dose).
- Patients on serotonergic agents that risk serotonin syndrome (e.g., tramadol, duloxetine).
- Pregnancy Category D: Use only if benefits outweigh risks.
Precautions:
- Baseline and periodic liver function tests; monitor for hepatotoxicity.
- Monitor blood pressure in the first 1–2 weeks of titration.
- Screen for QTc prolongation (baseline ECG).
- Avoid sudden withdrawal from other serotonergic drugs to prevent serotonin syndrome. |
| D. Practical Clinical Scenario | Patient: 54‑year‑old male, 10‑year history of hypertension on amlodipine 10 mg daily, presents with new-onset depression and insomnia. He reports no alcohol use, is not a smoker, denies illicit drugs, has normal BMI (24 kg/m²). Baseline labs: CBC, CMP, fasting glucose, lipid panel all within normal limits. |
| Step‑by‑step | 1. Baseline assessment: Document PHQ‑9 score (≥10 indicates moderate depression), insomnia severity index; confirm no contraindications to antidepressants. 2. Consider medication choice: SSRIs are first line for mild‑to‑moderate depression, but may interact with amlodipine? Minimal risk. 3. Drug–drug interaction screening: Use online tools (e.g., Lexicomp) to confirm no major interactions between the chosen SSRI and amlodipine. 4. Dose titration schedule: Start at low dose of SSRI (e.g., sertraline 25 mg/day), increase after 2‑3 weeks if tolerated. 5. Monitoring plan: Reassess BP, heart rate, and depressive symptoms every 4‑6 weeks; check for orthostatic hypotension due to combined antihypertensive effects. 6. Patient education: Discuss potential side effects (e.g., dizziness, nausea) and the importance of adherence. 7. Documentation: Record dose changes, tolerability, and any adverse events in EMR.

- Potential Challenges:
- Drug‑drug interactions between antihypertensives and antidepressants can lead to hypotension or bradycardia.
- Antidepressant-induced orthostatic hypotension may compound the effect of multiple antihypertensives.
- Patient adherence may be compromised due to polypharmacy burden.

- Strategies for Addressing Challenges:
1. Medication Review: Conduct regular medication reconciliation sessions, focusing on drug interactions and cumulative antihypertensive load.
2. Titration Protocols: Adopt a slow titration schedule with frequent monitoring of blood pressure (both supine and standing) after dosage adjustments.
3. Patient Education: Provide clear instructions about potential side effects such as dizziness or lightheadedness, emphasizing the importance of reporting these promptly.
4. Use of Decision Support Tools: Integrate clinical decision support systems that flag high-risk combinations and suggest alternative agents (e.g., preferring ACE inhibitors over ARBs in certain contexts).
5. Follow-Up Schedule: Implement a structured follow-up plan, with visits at 1 week, 2 weeks, and 4 weeks post-adjustment to reassess both blood pressure control and tolerability.

---

#### 3. Monitoring Protocols for Potential Adverse Effects

| Adverse Effect | Monitoring Parameter | Frequency / Method | Action Threshold / Intervention |
|--------------------|--------------------------|------------------------|-------------------------------------|
| Hyperkalemia | Serum potassium (K⁺) | Baseline, 1 week after dose change, then monthly if stable | If K⁺ >5.5 mEq/L → Reduce dosage or add loop diuretic; consider K⁺ binder |
| Renal dysfunction | eGFR / CrCl | Baseline, 2 weeks post-dose change, then quarterly | If decline >30% from baseline → Reassess dose; discontinue if needed |
| Hypotension (orthostatic) | Systolic BP supine & standing | Baseline, every visit | If symptomatic hypotension → Reduce dose or shift to morning dosing |
| Hyperkalemia | Serum K⁺ | Baseline, 2 weeks post-dose change, then quarterly | Same as above; consider adding diuretic or potassium binder |

---

### 5. Follow‑Up Schedule (First 12 Months)

| Time | Evaluation |
|------|------------|
| Weeks 1–4 | Phone call at week 2 to assess tolerance & BP. |
| Week 6 | Clinic visit: BP, weight, electrolytes (Na⁺, K⁺), renal function; review adherence. |
| Month 3 | Full evaluation as above plus 24‑h ambulatory BP if available. |
| Month 6 | Repeat labs; adjust dose if needed. |
| Month 9 | Check BP and labs again. |
| Month 12 | Final assessment: BP, weight, electrolytes, renal function, patient satisfaction. |

---

### 4. Potential Drug–Drug Interactions & Contraindications

| Interaction/Condition | Effect | Management |
|------------------------|--------|------------|
| ACE inhibitors or ARBs | Additive hypotension; increased serum creatinine / hyperkalemia | Use with caution; monitor renal function and electrolytes; consider dose reduction of either agent. |
| Loop diuretics (e.g., furosemide) | Potentially synergistic natriuresis, risk of volume depletion | Monitor BP, electrolytes; adjust doses accordingly. |
| NSAIDs | Reduce renin‑stimulated vasoconstriction; can blunt efficacy and worsen renal function | Use cautiously; monitor renal function. |
| Potassium‑sparing diuretics / potassium supplements | Risk of hyperkalemia (especially with ACE inhibitors/ARBs) | Monitor serum potassium regularly. |
| Digoxin | May have altered pharmacokinetics due to fluid shifts | Monitor levels if co‑administered. |

Always check for drug interactions and monitor renal function, electrolytes, and blood pressure when initiating or adjusting therapy.

---

## 5. Practical Clinical Recommendations

| Situation | Recommendation |
|-----------|----------------|
| Newly diagnosed HFpEF | 1. Treat comorbidities (HTN, DM, CKD) aggressively.
2. Initiate ACE‑I/ARB if tolerated; add ARNI if EF >40% and patient has symptoms or diastolic dysfunction.
3. Consider mineralocorticoid receptor antagonist for persistent congestion or hypertension.
4. Use SGLT‑2i as a first‑line agent when diabetic or CKD is present; otherwise consider if evidence emerges. |
| Patient with HFpEF + CKD | 1. Prefer ARNI over ACE‑I/ARB if renal function stable (eGFR >30).
2. Monitor creatinine and potassium closely.
3. If eGFR 140/90 mmHg.
3. Monitor for orthostatic hypotension in elderly. |

---

## 6. Practical Management Plan

| Step | Action | Timing | Rationale |
|----------|------------|-------------|---------------|
| Baseline Evaluation | CBC, CMP, fasting lipid panel, HbA1c, TSH, ECG, echocardiogram (if not recent), urine albumin/creatinine ratio. | At presentation | Establish disease severity and organ involvement. |
| Lifestyle Counseling | Dietary modification (DASH or Mediterranean diet), weight loss 5‑10 % if BMI >25, smoking cessation, moderate alcohol (

Kristy Whitty, 19 years

I am Jimmy from Cairnbrogie studying Biological Sciences. I did my schooling, secured 80% and hope to find someone with same interests in Slot Car Racing.

I'm Ray and I live in a seaside city in northern Italy, San Floriano Del Collio. I'm 21 and I'm will soon finish my study at History.

Hi!
My name is Efren and I'm a 17 years old boy from Netherlands.

Hello! My name is Hassie.
It is a little about myself: I live in Norway, my city of Haugesund.
It's called often Northern or cultural capital of NA. I've married 2 years ago.
I have two children - a son (Elizbeth) and the daughter (Anastasia). We all like Photography.

My name is Iola Kinard but everybody calls me Iola. I'm from France. I'm studying at the university (final year) and I play the Dobro for 8 years. Usually I choose music from the famous films :).
I have two brothers. I like Woodworking, watching movies and People watching.

Nothing to say about me really.

I'm Horacio and I live with my husband and our 2 children in Sao Paulo, in the SP south area. My hobbies are Skiing, Crocheting and Auto audiophilia.

I’m Jaclyn from Porto Alegre studying English Literature. I did my schooling, secured 79% and hope to find someone with same interests in Travel.

Ik ben een specialist in het opsporen van de meest lucratieve casino bonussen en promoties. Sta mij toe je navigeren naar het maximale voordeel.

Hi there! :) My name is Marylin, I'm a student studying Biochemistry from Milford, Great Britain.

Hello! My name is Dante.
It is a little about myself: I live in Great Britain, my city of Rackenford.
It's called often Northern or cultural capital of NA. I've married 1 years ago.
I have 2 children - a son (Rolland) and the daughter (Darla). We all like Swimming.

My entire digital presence is built upon the Sky Bet login. I am here to steer you through its every nuance.

Faites confiance à votre partenaire idéal outil de comparaison de casinos et jouez malin !

Mijn streven is om van jou een slimmere speler te maken. Ik bied de hulpmiddelen die je daarvoor nodig hebt.

Meet new and interesting people.

Beitreten NRI MatchMaking Matrimony Profiles, wo man jeden treffen könnte, überall!

I am a keen pioneer of everything the wplay realm, dissecting its inner functions and imparting game-changing perceptions. My purpose is to enable other participants to elevate their game and genuinely conquer the cyber domain.

Beste Dating-Website für jedes Alter

Wir haben es Ihnen leicht gemacht, Spaß zu haben, während Sie unsere Quickdate-Plattform nutzen.

Benutzerkonto erstellen

Übereinstimmungen finden

Starte die Partnersuche

Finden Sie Ihre beste Übereinstimmung

Vollständig sicher und verschlüsselt

100% Datenschutz

Warum Quickdate die beste Plattform ist?

Verbinde dich hier mit deinem perfekten Soulmate auf NRI MatchMaking Matrimony Profiles.

Schnelle Links

Immer auf dem Laufenden mit unseren neuesten Angeboten und Rabatten!

Folge uns!

Bist du 18 Jahre oder älter?

I am Jimmy from Cairnbrogie studying Biological Sciences. I did my schooling, secured 80% and hope to find someone with same interests in Slot Car Racing.

I'm Ray and I live in a seaside city in northern Italy, San Floriano Del Collio. I'm 21 and I'm will soon finish my study at History.

Hi! My name is Efren and I'm a 17 years old boy from Netherlands.

Hello! My name is Hassie. It is a little about myself: I live in Norway, my city of Haugesund. It's called often Northern or cultural capital of NA. I've married 2 years ago. I have two children - a son (Elizbeth) and the daughter (Anastasia). We all like Photography.

My name is Iola Kinard but everybody calls me Iola. I'm from France. I'm studying at the university (final year) and I play the Dobro for 8 years. Usually I choose music from the famous films :). I have two brothers. I like Woodworking, watching movies and People watching.

Nothing to say about me really.

I'm Horacio and I live with my husband and our 2 children in Sao Paulo, in the SP south area. My hobbies are Skiing, Crocheting and Auto audiophilia.

I’m Jaclyn from Porto Alegre studying English Literature. I did my schooling, secured 79% and hope to find someone with same interests in Travel.

Ik ben een specialist in het opsporen van de meest lucratieve casino bonussen en promoties. Sta mij toe je navigeren naar het maximale voordeel.

Hi there! :) My name is Marylin, I'm a student studying Biochemistry from Milford, Great Britain.

Hello! My name is Dante. It is a little about myself: I live in Great Britain, my city of Rackenford. It's called often Northern or cultural capital of NA. I've married 1 years ago. I have 2 children - a son (Rolland) and the daughter (Darla). We all like Swimming.

My entire digital presence is built upon the Sky Bet login. I am here to steer you through its every nuance.

Faites confiance à votre partenaire idéal outil de comparaison de casinos et jouez malin !

Mijn streven is om van jou een slimmere speler te maken. Ik bied de hulpmiddelen die je daarvoor nodig hebt.

Meet new and interesting people.

Beitreten NRI MatchMaking Matrimony Profiles, wo man jeden treffen könnte, überall!

I am a keen pioneer of everything the wplay realm, dissecting its inner functions and imparting game-changing perceptions. My purpose is to enable other participants to elevate their game and genuinely conquer the cyber domain.

Beste Dating-Website für jedes Alter

Wir haben es Ihnen leicht gemacht, Spaß zu haben, während Sie unsere Quickdate-Plattform nutzen.

Benutzerkonto erstellen

Übereinstimmungen finden

Starte die Partnersuche

Finden Sie Ihre beste Übereinstimmung

Vollständig sicher und verschlüsselt

100% Datenschutz

Warum Quickdate die beste Plattform ist?

Verbinde dich hier mit deinem perfekten Soulmate auf NRI MatchMaking Matrimony Profiles.

Schnelle Links

Immer auf dem Laufenden mit unseren neuesten Angeboten und Rabatten!

Folge uns!

Sprache

Hi!
My name is Efren and I'm a 17 years old boy from Netherlands.

Hello! My name is Hassie.
It is a little about myself: I live in Norway, my city of Haugesund.
It's called often Northern or cultural capital of NA. I've married 2 years ago.
I have two children - a son (Elizbeth) and the daughter (Anastasia). We all like Photography.

My name is Iola Kinard but everybody calls me Iola. I'm from France. I'm studying at the university (final year) and I play the Dobro for 8 years. Usually I choose music from the famous films :).
I have two brothers. I like Woodworking, watching movies and People watching.

Hello! My name is Dante.
It is a little about myself: I live in Great Britain, my city of Rackenford.
It's called often Northern or cultural capital of NA. I've married 1 years ago.
I have 2 children - a son (Rolland) and the daughter (Darla). We all like Swimming.